Skip to main content

Table 3 Subgroup analysis results by chemotherapy, baseline FPG and NLR

From: Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer

Stratification variable

Stratum

Elevated serum GGT (> 48 U/L)

Adjusted HR (95% CI)

Interaction

p-value

Palliative chemotherapy

Yes

1.70 (1.16, 2.51) a

0.84

No

1.61 (1.10, 2.34) a

Baseline NLR

≥ 4.46

1.38 (0.95, 2.00) b

0.91

<  4.46

1.42 (0.99, 2.03) b

Baseline FPG

≥ 7.0 mmol/L

1.31 (0.90, 1.92) c

0.07

<  7.0 mmol/L

2.14 (1.48, 3.09) c

  1. a Adjusted for age at diagnosis, baseline NLR, baseline FPG
  2. b Adjusted for age at diagnosis, palliative chemotherapy, baseline FPG
  3. c Adjusted for age at diagnosis, palliative chemotherapy, baseline NLR